Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
Saved in:
| Title: | Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. |
|---|---|
| Authors: | Hincelin-Mery A; Sanofi, Chilly-Mazarin, France., Nicolas X; Sanofi, Montpellier, France., Cantalloube C; Sanofi, Chilly-Mazarin, France., Pomponio R; Sanofi, Cambridge, Massachusetts, USA., Lewanczyk P; Ividata Life Sciences, Levallois-Perret, France., Benamor M; Sanofi, Chilly-Mazarin, France., Ofengeim D; Sanofi, Cambridge, Massachusetts, USA., Krupka E; Sanofi, Montpellier, France., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, California, USA., Eastenson A; Nucleus Network Pty Ltd., St. Paul, Minnesota, USA., Atassi N; Sanofi, Cambridge, Massachusetts, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13690. Date of Electronic Publication: 2023 Dec 11. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38010108 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hincelin-Mery+A%22">Hincelin-Mery A</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+X%22">Nicolas X</searchLink>; Sanofi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Cantalloube+C%22">Cantalloube C</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Pomponio+R%22">Pomponio R</searchLink>; Sanofi, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lewanczyk+P%22">Lewanczyk P</searchLink>; Ividata Life Sciences, Levallois-Perret, France.<br /><searchLink fieldCode="AU" term="%22Benamor+M%22">Benamor M</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Ofengeim+D%22">Ofengeim D</searchLink>; Sanofi, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Krupka+E%22">Krupka E</searchLink>; Sanofi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Hsiao-Nakamoto+J%22">Hsiao-Nakamoto J</searchLink>; Denali Therapeutics Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Eastenson+A%22">Eastenson A</searchLink>; Nucleus Network Pty Ltd., St. Paul, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Atassi+N%22">Atassi N</searchLink>; Sanofi, Cambridge, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13690. <i>Date of Electronic Publication: </i>2023 Dec 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38010108 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.13690 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e13690 Titles: – TitleFull: Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hincelin-Mery A – PersonEntity: Name: NameFull: Nicolas X – PersonEntity: Name: NameFull: Cantalloube C – PersonEntity: Name: NameFull: Pomponio R – PersonEntity: Name: NameFull: Lewanczyk P – PersonEntity: Name: NameFull: Benamor M – PersonEntity: Name: NameFull: Ofengeim D – PersonEntity: Name: NameFull: Krupka E – PersonEntity: Name: NameFull: Hsiao-Nakamoto J – PersonEntity: Name: NameFull: Eastenson A – PersonEntity: Name: NameFull: Atassi N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Jan Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1752-8062 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Clinical and translational science Type: main |
| ResultId | 1 |